Washington Trust Advisors’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-19
Closed -$444 – 743
2026
Q1
$444 Sell
19
-42
-69% -$1.31K ﹤0.01% 678
2025
Q4
$2.68K Buy
+61
New +$3.42K ﹤0.01% 568
2024
Q4
– Sell
-149
Closed -$7.3K – 660
2024
Q3
$6.49K Hold
149
– – ﹤0.01% 541
2024
Q2
$4.17K Sell
149
-90
-38% -$2.37K ﹤0.01% 584
2024
Q1
$6.42K Sell
239
-139
-37% -$3.96K ﹤0.01% 538
2023
Q4
$10.6K Buy
378
+105
+38% +$2.48K ﹤0.01% 463
2023
Q3
$5.78K Buy
273
+14
+5% +$382 ﹤0.01% 530
2023
Q2
$8.8K Sell
259
-417
-62% -$13.9K ﹤0.01% 478
2023
Q1
$21.9K Buy
676
+172
+34% +$5.71K ﹤0.01% 408
2022
Q4
$16.9K Sell
504
-630
-56% -$19.2K ﹤0.01% 442
2022
Q3
$34K Buy
1,134
+172
+18% +$6.3K ﹤0.01% 443
2022
Q2
$33K Buy
962
+428
+80% +$16.9K ﹤0.01% 459
2022
Q1
$28K Buy
+534
New +$26.9K ﹤0.01% 538

Other funds holding DOCS

Washington Trust Advisors's DOCS Position: Q2 2026 in Review

Washington Trust Advisors sold out of Doximity (DOCS) in Q2 2026, closing a stake of 19 shares — an estimated $444 sold.

Washington Trust Advisors first reported a position in DOCS in Q1 2022 and held it in 13 quarters. The position peaked at $34K in Q3 2022. 359 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Washington Trust Advisors reported no remaining Doximity position as of Q2 2026 after selling out during the quarter.
  • Washington Trust Advisors sold 19 Doximity shares in Q2 2026, an estimated $444.
  • Washington Trust Advisors first reported a position in Doximity in Q1 2022 and held it in 13 quarters.
  • Washington Trust Advisors's Doximity position peaked at $34K in Q3 2022.
  • 359 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.